| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |